Boston Scientific Corporation (BSX)

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	725	414	865	928	1,925	1,734
Cash & Short-Term Investments	725	414	865	928	1,925	1,734
Cash Growth	-68.87%	-52.14%	-6.79%	-51.79%	11.02%	699.08%
Accounts Receivable	2,693	2,558	2,228	1,970	1,778	1,531
Receivables	2,693	2,558	2,228	1,970	1,778	1,531
Inventory	2,867	2,810	2,484	1,867	1,610	1,351
Restricted Cash	103	111	130	149	188	208
Other Current Assets	947	1,027	807	846	816	1,870
Total Current Assets	7,335	6,920	6,514	5,760	6,317	6,694
Property, Plant & Equipment	3,837	3,743	3,298	2,832	2,687	2,542
Long-Term Investments	654	556	413	407	411	918
Goodwill	17,340	17,089	14,387	12,920	11,988	9,951
Other Intangible Assets	6,566	6,684	6,003	5,969	6,235	6,135
Long-Term Deferred Tax Assets	3,676	3,655	3,841	3,942	4,142	4,210
Other Long-Term Assets	732	748	680	639	449	327
Total Assets	40,140	39,395	35,136	32,469	32,229	30,777
Accounts Payable	1,004	960	942	862	794	513
Accrued Expenses	2,103	2,533	2,136	1,855	1,883	1,666
Current Portion of Long-Term Debt	777	1,778	531	20	261	13
Current Portion of Leases	-	81	76	61	71	70
Current Income Taxes Payable	315	268	220	232	209	158
Current Unearned Revenue	306	306	266	220	208	138
Other Current Liabilities	553	473	762	553	848	1,123
Total Current Liabilities	5,058	6,399	4,933	3,803	4,274	3,681
Long-Term Debt	10,406	8,842	8,566	8,910	8,798	9,123
Long-Term Leases	525	527	395	352	395	408
Long-Term Unearned Revenue	335	329	311	289	276	257
Long-Term Deferred Tax Liabilities	158	155	134	144	310	330
Other Long-Term Liabilities	1,213	1,140	1,267	1,398	1,554	1,652
Total Liabilities	17,695	17,392	15,606	14,896	15,607	15,451
Common Stock	17	17	17	17	17	17
Additional Paid-In Capital	21,127	21,056	20,647	20,289	19,986	19,732
Retained Earnings	3,347	2,673	819	-750	-1,392	-2,378
Treasury Stock	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251
Comprehensive Income & Other	-28	275	50	268	262	206
Total Common Equity	22,212	21,770	19,282	17,573	16,622	15,326
Minority Interest	233	233	248	-	-	-
Shareholders' Equity	22,445	22,003	19,530	17,573	16,622	15,326
Total Liabilities & Equity	40,140	39,395	35,136	32,469	32,229	30,777
Total Debt	11,708	11,228	9,568	9,343	9,525	9,614
Net Cash (Debt)	-10,983	-10,814	-8,703	-8,415	-7,600	-7,880
Net Cash Per Share	-7.38	-7.28	-5.95	-5.84	-5.30	-5.56
Filing Date Shares Outstanding	1,479	1,476	1,467	1,435	1,427	1,417
Total Common Shares Outstanding	1,479	1,475	1,466	1,433	1,426	1,417
Working Capital	2,277	521	1,581	1,957	2,043	3,013
Book Value Per Share	15.02	14.76	13.16	12.26	11.66	10.82
Tangible Book Value	-1,694	-2,003	-1,108	-1,316	-1,601	-760
Tangible Book Value Per Share	-1.15	-1.36	-0.76	-0.92	-1.12	-0.54
Land	145	144	140	137	109	104
Buildings	2,096	2,019	1,843	1,695	1,523	1,292
Machinery	3,781	3,629	3,503	3,298	3,288	3,466
Construction In Progress	1,009	1,035	857	598	605	446

Updated Apr 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q